ABATA Trademark
ABATA is a USPTO trademark filed by Abata Therapeutics, Inc.. Status: Abandoned.
Trademark Facts
| Mark | ABATA |
|---|---|
| Serial Number | 98909678 |
| Status | Abandoned |
| Filing Date | 2024-12-18 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 040 (Material Treatment) |
| Owner | Abata Therapeutics, Inc. |
| Attorney of Record | Susan Piascik Christoff |
| Prosecution Events | 10 |
| Latest Event | MAB6 on 2026-04-13 |
Goods & Services
Custom manufacture of therapeutic drugs, namely, custom manufacture of cell and gene therapies; custom manufacturing for others, namely, manufacturing of pharmaceutical preparations for health care, for the treatment of humans suffering from diseases treated by cell therapy or gene therapy or regenerative medicine products, more specifically medicines for human use as well as medicines for experimental medical and therapeutic uses, biological products for experimental purposes, preparations for cell therapy, gene therapy, and medicines for innovative therapies; Pharmaceutical preparations for cell therapy, namely pharmaceutical preparations for T cell therapy; pharmaceutical preparations and vaccines for use in gene therapy and cell therapy; biological preparations for use in medical and clinical gene therapy and cell therapy for the treatment of cancer, autoimmune diseases, neurological disorders, inflammatory conditions, transplant complications, and immunological disorders; pharmaceutical products for the prevention and treatment of cancer, autoimmune diseases, neurological disorders, inflammatory conditions, transplant complications, and immunological disorders; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, neurological disorders, inflammatory conditions, transplant complications, and immunological disorders; biological preparations for the treatment of cancer, autoimmune diseases, neurological disorders, inflammatory disorders, transplant complications, and immunological disorders; chemical and biochemical preparations for medical purposes, specifically, for the treatment and diagnosis of cancer, autoimmune diseases, neurological disorders, inflammatory conditions, transplant complications, and immunological disorders; biochemical, namely, monoclonal antibodies for medical purposes, specifically, for the treatment and diagnosis of cancer, autoimmune diseases, neurological disorders, inflammatory conditions, transplant complications, and immunological disorders